Prescription monitoring of hypertensive patients referred to hypertension out patient department of a tertiary care hospital, Mumbai.

Jagdish Nigade, Shetty Y, Billa G, Salagre S, Rege N

Jagdish Nigade, Shetty Y, Billa G, Salagre S, Rege N

Keywords: anti-hypertensive drugs, drug utilisation, hypertension, prescribing pattern, Awareness

Abstract

Introduction: The present study tried to establish the prescribing pattern, rationality of prescriptions and the awareness of patients about hypertension and the medicines given to them.
Methods: This study of nine-month duration was conducted at the Hypertension Clinic in KEM hospital after obtaining permission from the IEC. The information was collected from new OPD patients of either sex with age between 18 and 80 years who were referred from intra hospital or from outside KEM hospital doctors for the first time, and who had received the prescription within last 6 months. Data collection was done using case record form (CRF) and a pre-validated questionnaire.
Results: Our study revealed that most of the patients were on monotherapy (53.92%). In the monotherapy category, the drugs used were calcium channel blockers (CCBs) 74.5%), beta-blockers (16.4%) and angiotensin converting enzyme (ACE) inhibitors (3.6%). Among those who were treated with drug combinations, 60.87% received two drugs, 26.09% received three drugs and 13.04% received four drugs. In combination therapy, beta-blocker and calcium channel blocker combination was given to the majority. Ninety seven percent prescriptions were incomplete in various aspects of non drug therapy and drug therapy. The most frequently prescribed non drug therapy was salt restricted diet (68.42%). Awareness of the participants was poor with regards to their disease, its complications and its therapy.
Conclusion: The present study represents the current prescribing trend for anti-hypertensive agents and it highlights certain shortcomings in the existing prescribing practice.

References

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.
2. Geeganage CM, Tracy M, Bath MW, Bath PMW. Blood pressure reduction and cardiovascular prevention: meta-regression using ordered categorical (ordinal) event data. Journal of hypertension. 2010;28(10):1995–9.
3. Chobanian A V, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72.
4. Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. Journal of the American Board of Family Medicine. 2007;20(1):72–80.
5. Roumie CL, Elasy TA, Greevy R, Griffin MR, Liu X, Stone WJ, et al. Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med. 2006 Aug 1;145(3):165-75.
6. No Title [Internet]. [cited 2014 Sep 17]. Available from: http://www.cdc.gov/nchs/data/nhanes/spq-bp.pdf
7. Shankarishan P, Borah PK, Mohapatra PK, Ahmed G, Mahanta J. Population attributable risk estimates for risk factors associated with hypertension in an Indian population. Eur J Prev Cardiol. 2013;20(6):963-71.
8. Ojji DB, Ajayi SO, Mamven MH, Alfa J, Albertino D. Pattern of prescription of anti-hypertensive medications in a tertiary health care facility in Abuja, Nigeria. Ethnicity & disease. Ethn Dis. 2013;23(4):480-3.
9. Salvetti A, Ghiadoni L. Thiazide diuretics in the treatment of hypertension: an update. Journal of the American Society of Nephrology. 2006;17(4 Suppl 2):S25–9.
10. Leon M-M, Mitu F. The clinical-epidemological study of drugs used to treat arterial hypertension and associated comorbidities. Rev Med Chir Soc Med Nat Iasi. 2013;117(2):488-94.
11. Richards TR, Tobe SW. Combining other antihypertensive drugs with β-blockers in hypertension: a focus on safety and tolerability. The Canadian journal of cardiology. 2014;30(5 Suppl):S42–6.
12. Margolis KL, Davis BR, Baimbridge C, Ciocon JO, Cuyjet AB, Dart RA, et al. Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). Journal of clinical hypertension. 2013;15(8):542–54.
13. Taddei S. Fixed-dose combination therapy in hypertension: pros. High Blood Press Cardiovasc Prev. 2012;19(2):55-7.
14. Rajpura JR, Nayak R. Role of illness perceptions and medication beliefs on medication compliance of elderly hypertensive cohorts. Journal of pharmacy practice. 2014;27(1):19–24.
15. Yi-Bing W, De-Gui K, Long-Le M, Le-Xin W. Patient related factors for optimal blood pressure control in patients with hypertension. African health sciences. 2013;13(3):579–83.
16. Tiwari H, Kumar A, Kulkarni SK. Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India. Singapore Med J. 2004;45(3):117-20.